Earnings Feed
Start Free
Home/Filings/4/0001127602-13-019912
4//SEC Filing

CONMED CORP 4

Accession 0001127602-13-019912

$CNMDCIK 0000816956operating
View on SEC.govCompany Profile

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 4:59 PM ET

Size

28.0 KB

Accession

0001127602-13-019912

Insider Transaction Report

Form 4
Period: 2013-06-07
CONMED CORPCNMD
CORASANTI EUGENE R
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2013-06-07$19.26/sh+500$9,630→ 77,001 total
  • Exercise/Conversion

    Sars (Stock Appreciation Rights)

    2013-06-07−500→ 1,000 total
    Exercise: $19.26Exp: 2020-06-01→ Common Stock (500 underlying)
  • Exercise/Conversion

    Sars (Stock Appreciation Rights)

    2013-06-07−500→ 1,500 total
    Exercise: $27.63Exp: 2021-06-01→ Common Stock (500 underlying)
  • Tax Payment

    Common Stock

    2013-06-07$32.38/sh−437$14,150→ 76,322 total
  • Exercise/Conversion

    Common Stock

    2013-06-07$27.63/sh+500$13,815→ 77,149 total
  • Tax Payment

    Common Stock

    2013-06-07$32.38/sh−447$14,474→ 76,702 total
  • Tax Payment

    Common Stock

    2013-06-07$32.38/sh−2,144$69,423→ 77,058 total
  • Exercise/Conversion

    Sars (Stock Appreciation Rights)

    2013-06-07−500→ 0 total
    Exercise: $26.69Exp: 2018-06-01→ Common Stock (500 underlying)
  • Exercise/Conversion

    Common Stock

    2013-06-07$26.69/sh+500$13,345→ 76,759 total
  • Exercise/Conversion

    Common Stock

    2013-06-07$16.46/sh+500$8,230→ 76,822 total
  • Exercise/Conversion

    Sars (Stock Appreciation Rights)

    2013-06-07−2,500→ 0 total
    Exercise: $26.09Exp: 2022-06-01→ Common Stock (2,500 underlying)
  • Tax Payment

    Common Stock

    2013-06-07$32.38/sh−321$10,394→ 76,501 total
  • Tax Payment

    Common Stock

    2013-06-07$32.38/sh−352$11,398→ 76,649 total
  • Exercise/Conversion

    Common Stock

    2013-06-07$26.09/sh+2,500$65,225→ 79,202 total
  • Exercise/Conversion

    Sars (Stock Appreciation Rights)

    2013-06-07−500→ 500 total
    Exercise: $16.46Exp: 2019-06-01→ Common Stock (500 underlying)
Footnotes (3)
  • [F1]The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.
  • [F2]The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
  • [F3]The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the SARs generally vesting 100% after a one year period.

Documents

1 file

Issuer

CONMED CORP

CIK 0000816956

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000816956

Filing Metadata

Form type
4
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:59 PM ET
Size
28.0 KB
View on SEC.gov